Brief: China Medical System Says Co, Via Unit, Entered An Asset Transfer With Wuhan Yzy Biopharma
July 26 (Reuters) - China Medical System Holdings Ltd
0867.HK :
* CO, VIA UNIT, ENTERED INTO AN ASSET TRANSFER WITH WUHAN
YZY
BIOPHARMA CO LTD
* AGREEMENT TO ACQUIRE ALL ASSETS RELATED TO VEGF/ANG2
TETRAVALENT
BISPECIFIC ANTIBODY FOR INTRAVITREAL INJECTION
Further company coverage: 0867.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on China Medical System Holdings
See all newsBrief: China Medical System Says CMS-D001 Granted Drug Clinical Trial Approval Notice By NMPA
Brief: China Medical System Holdings Says Dermavon Receives NMPA Approval For Lumirix NDA For Atopic Dermatitis
China Medical System climbs most in six weeks on higher profit, dividend
China Medical System H1 revenue rises on jump in sales of innovative and exclusive products
AI shortens drug discovery to around 1 year in China, Insilico CEO says